心臓バイオマーカー市場規模- 製品、用途、最終用途別- 世界予測、2023-2032年

心臓バイオマーカー市場規模は2023年から2032年にかけてCAGR 12.8%を記録する見込み世界中で心血管疾患の有病率が上昇し、高齢化も相まって、高度な診断ツールの必要性が高まっています。

世界心臓連盟（WHF）の新しい報告書によると、2021年には心血管（CVD）が原因で約2,050万人が死亡しています。

最先端技術の登場と早期発見の重要性の高まりにより、臨床における心臓バイオマーカーの重要性が高まっています。タンパク質から遺伝子マーカーまで、これらのバイオマーカーは、心血管疾患の予測、診断、管理においてヘルスケア専門家にとって不可欠なツールになりつつあり、その結果、心臓治療の展望が再構築されつつあります。

心臓バイオマーカー市場は、製品、用途、最終用途、地域によって分類されます。

ナトリウム利尿ペプチド分野は、2032年までに莫大な収益を上げると予測されています。ナトリウム利尿ペプチド、特にB型ナトリウム利尿ペプチド（BNP）とN末端プロB型ナトリウム利尿ペプチド（NT-proBNP）は、心不全の極めて重要な指標となっています。これらのペプチドは心臓のストレスや機能障害を検出する精度と感度が高いため、ヘルスケア提供者の間で広く注目されています。技術の進歩に伴い、新しいナトリウム利尿ペプチド測定法の開発は診断精度の向上を約束し、臨床医に早期介入と個別化された治療戦略のための強力な武器を提供します。

うっ血性心不全（CHF）応用分野は、世界の心不全の流行に牽引され、2032年まで心臓バイオマーカーの高い需要を生み出すと思われます。CHF症例数の驚異的な増加に伴い、トロポニン、クレアチンキナーゼ-MB（CK-MB）、ミオグロビンなどのCHFバイオマーカーが心機能の包括的評価に役立っています。これらのバイオマーカーを日常臨床に取り入れることで、心不全管理のアプローチが再構築され、タイムリーな介入が可能になり、患者の転帰が改善されます。

欧州の心臓バイオマーカー産業は、2023年から2032年にかけて強力なCAGRを記録すると予測されています。これは、予防対策と個別化医療を重視する心血管系医療のパラダイムシフトが後押ししています。ヘルスケア施設と革新的な診断企業間の共同努力により、日常臨床への製品統合が勢いを増しています。欧州地域が最新の進歩を受け入れ続けるにつれて、市場は持続的な成長を遂げ、同大陸全域で心血管医療の新時代が到来します。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 心臓バイオマーカー業界考察

• COVID-19インパクト分析
• エコシステム分析
• 技術情勢
• 規制状況
• 業界への影響要因
  • 促進要因
    • 心血管疾患の有病率の増加
    • 高齢者人口の増加による心臓関連疾患の有病率の上昇
    • 新たな心臓バイオマーカーの発見を目的とした臨床研究の増加
    • ポイントオブケア検査の増加
  • 業界の潜在的リスク＆課題
    • 厳しい規制の枠組み
    • 心臓画像技術の存在と進歩
• 成長可能性分析
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
  • Abbott Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
• 主要市場プレーヤーの競合分析
• 競合のポジショニング・マトリックス
• 戦略的展望マトリックス

第5章 心臓バイオマーカー市場規模・予測：製品別、2018年～2032年

• 主要動向：製品別
• トロポニン
• クレアチンキナーゼ-MB（CK-MB）
• ミオグロビン
• ナトリウム利尿ペプチド
• C反応性蛋白（CRP）
• 虚血修飾アルブミン
• その他の製品

第6章 心臓バイオマーカー市場規模・予測：用途別、2018年～2032年

• 主要動向：用途別
• うっ血性心不全
• 心筋梗塞
• 急性冠症候群
• アテローム性動脈硬化症
• その他

第7章 心臓バイオマーカー市場規模・予測：最終用途別、2018年～2032年

• 主要動向：エンドユーザー別
• 病院検査室
• ポイントオブケア検査施設
• 診断施設
• その他のエンドユーザー

第8章 心臓バイオマーカー市場規模・予測：地域別、2018年～2032年

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • その他中東とアフリカ

第9章 企業プロファイル

• Abbott Diagnostics
• Roche Diagnostics
• Siemens Healthineers
• Beckman Coulter
• Bio-Rad Laboratories
• Ortho Clinical Diagnostics
• Randox Laboratories
• Quidel Corporation
• Radiometer
• Tosoh Corporation
• Meso Scale Diagnostics（MSD）
• Thermo Fisher Scientific
• Luminex Corporation
• Trinity Biotech
• Biomerieux

Data Tables

• TABLE 1 Industry impact forces
• TABLE 2 Competitive analysis of major market players
• TABLE 3 Competitive positioning matrix: Classification criteria
• TABLE 4 Troponins market size, 2018 - 2024 (USD Million)
• TABLE 5 Troponins market size, 2025 - 2032 (USD Million)
• TABLE 6 CK-MB market size, 2018 - 2024 (USD Million)
• TABLE 7 CK-MB market size, 2025 - 2032 (USD Million)
• TABLE 8 Myoglobin market size, 2018 - 2024 (USD Million)
• TABLE 9 Myoglobin market size, 2025 - 2032 (USD Million)
• TABLE 10 Natriuretic peptides market size, 2018 - 2024 (USD Million)
• TABLE 11 Natriuretic peptides market size, 2025 - 2032 (USD Million)
• TABLE 12 CRP market size, 2018 - 2024 (USD Million)
• TABLE 13 CRP market size, 2025 - 2032 (USD Million)
• TABLE 14 Ischemia modified albumin market size, 2018 - 2024 (USD Million)
• TABLE 15 Ischemia modified albumin market size, 2025 - 2032 (USD Million)
• TABLE 16 Other products market size, 2018 - 2024 (USD Million)
• TABLE 17 Other products market size, 2025 - 2032 (USD Million)
• TABLE 18 Congestive heart failure market size, 2018 - 2024 (USD Million)
• TABLE 19 Congestive heart failure market size, 2025 - 2032 (USD Million)
• TABLE 20 Myocardial infarction market size, 2018 - 2024 (USD Million)
• TABLE 21 Myocardial infarction market size, 2025 - 2032 (USD Million)
• TABLE 22 Acute coronary syndrome market size, 2018 - 2024 (USD Million)
• TABLE 23 Acute coronary syndrome market size, 2025 - 2032 (USD Million)
• TABLE 24 Atherosclerosis market size, 2018 - 2024 (USD Million)
• TABLE 25 Atherosclerosis market size, 2025 - 2032 (USD Million)
• TABLE 26 Other application market size, 2018 - 2024 (USD Million)
• TABLE 27 Other application market size, 2025 - 2032 (USD Million)
• TABLE 28 Hospital laboratory market size, 2018 - 2024 (USD Million)
• TABLE 29 Hospital laboratory market size, 2025 - 2032 (USD Million)
• TABLE 30 Point of care testing facilities market size, 2018 - 2024 (USD Million)
• TABLE 31 Point of care testing facilities market size, 2025 - 2032 (USD Million)
• TABLE 32 Diagnostic facilities market size, 2018 - 2024 (USD Million)
• TABLE 33 Diagnostic facilities market size, 2025 - 2032 (USD Million)
• TABLE 34 Other end-users market size, 2018 - 2024 (USD Million)
• TABLE 35 Other end-users market size, 2025 - 2032 (USD Million)
• TABLE 36 North America cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 37 North America cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 38 North America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 39 North America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 40 North America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 41 North America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 42 North America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 43 North America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 44 U.S. cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 45 U.S. cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 46 U.S. cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 47 U.S. cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 48 U.S. cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 49 U.S. cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 50 Canada cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 51 Canada cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 52 Canada cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 53 Canada cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 54 Canada cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 55 Canada cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 56 Europe cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 57 Europe cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 58 Europe cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 59 Europe cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 60 Europe cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 61 Europe cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 62 Europe cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 63 Europe cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 64 Germany cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 65 Germany cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 66 Germany cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 67 Germany cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 68 Germany cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 69 Germany cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 70 UK cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 71 UK cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 72 UK cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 73 UK cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 74 UK cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 75 UK cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 76 France cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 77 France cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 78 France cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 79 France cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 80 France cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 81 France cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 82 Italy cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 83 Italy cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 84 Italy cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 85 Italy cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 86 Italy cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 87 Italy cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 88 Spain cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 89 Spain cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 90 Spain cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 91 Spain cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 92 Spain cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 93 Spain cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 94 Rest of Europe cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 95 Rest of Europe cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 96 Rest of Europe cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 97 Rest of Europe cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 98 Rest of Europe cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 99 Rest of Europe cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 100 Asia Pacific cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 101 Asia Pacific cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 102 Asia Pacific cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 103 Asia Pacific cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 104 Asia Pacific cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 105 Asia Pacific cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 106 Asia Pacific cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 107 Asia Pacific cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 108 China cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 109 China cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 110 China cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 111 China cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 112 China cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 113 China cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 114 Japan cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 115 Japan cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 116 Japan cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 117 Japan cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 118 Japan cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 119 Japan cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 120 India cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 121 India cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 122 India cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 123 India cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 124 India cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 125 India cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 126 Australia cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 127 Australia cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 128 Australia cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 129 Australia cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 130 Australia cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 131 Australia cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 132 South Korea cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 133 South Korea cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 134 South Korea cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 135 South Korea cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 136 South Korea cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 137 South Korea cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 138 Rest of Asia Pacific cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 139 Rest of Asia Pacific cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 140 Rest of Asia Pacific cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 141 Rest of Asia Pacific cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 142 Rest of Asia Pacific cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 143 Rest of Asia Pacific cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 144 Latin America cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 145 Latin America cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 146 Latin America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 147 Latin America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 148 Latin America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 149 Latin America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 150 Latin America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 151 Latin America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 152 Brazil cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 153 Brazil cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 154 Brazil cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 155 Brazil cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 156 Brazil cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 157 Brazil cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 158 Mexico cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 159 Mexico cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 160 Mexico cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 161 Mexico cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 162 Mexico cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 163 Mexico cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 164 Argentina cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 165 Argentina cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 166 Argentina cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 167 Argentina cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 168 Argentina cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 169 Argentina cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 170 Rest of Latin America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 171 Rest of Latin America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 172 Rest of Latin America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 173 Rest of Latin America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 174 Rest of Latin America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 175 Rest of Latin America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 176 Middle East & Africa cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
• TABLE 177 Middle East & Africa cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
• TABLE 178 Middle East & Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 179 Middle East & Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 180 Middle East & Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 181 Middle East & Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 182 Middle East & Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 183 Middle East & Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 184 Saudi Arabia cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 185 Saudi Arabia cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 186 Saudi Arabia cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 187 Saudi Arabia cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 188 Saudi Arabia cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 189 Saudi Arabia cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 190 South Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 191 South Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 192 South Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 193 South Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 194 South Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 195 South Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 196 UAE cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 197 UAE cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 198 UAE cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 199 UAE cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 200 UAE cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 201 UAE cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
• TABLE 202 Rest of Middle East & Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
• TABLE 203 Rest of Middle East & Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
• TABLE 204 Rest of Middle East & Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
• TABLE 205 Rest of Middle East & Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
• TABLE 206 Rest of Middle East & Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
• TABLE 207 Rest of Middle East & Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)

Charts & Figures

• FIG. 1 Research design
• FIG. 2 Data collection techniques
• FIG. 3 Primary research process
• FIG. 4 Market sizing approach
• FIG. 5 Forecasting model
• FIG. 6 Global industry snapshot
• FIG. 7 Industry ecosystem analysis
• FIG. 8 Growth potential analysis, by product
• FIG. 9 Growth potential analysis, by application
• FIG. 10 Growth potential analysis, by end-use
• FIG. 11 Porter's analysis
• FIG. 12 PESTEL analysis
• FIG. 13 Company market share analysis, 2022
• FIG. 14 Competitive analysis of major market players, 2022
• FIG. 15 Competitive positioning matrix, 2022
• FIG. 16 Strategic outlook matrix, 2022

Cardiac biomarkers market size is expected to record 12.8% CAGR from 2023 to 2032. The rising prevalence of cardiovascular diseases worldwide, coupled with an aging population, has spurred the need for advanced diagnostic tools. According to a new report from the World Heart Federation (WHF), nearly 20.5 million deaths happened due to cardiovascular (CVD) in 2021.

The advent of cutting-edge technologies and the growing emphasis on early detection have elevated the importance of cardiac biomarkers in clinical practice. These biomarkers, ranging from proteins to genetic markers, are becoming indispensable tools for healthcare professionals in predicting, diagnosing, and managing cardiovascular conditions, thus reshaping the landscape of cardiac care.

The cardiac biomarkers market is classified based on product, application, end-use, and region.

The natriuretic peptides segment is predicted to generate massive revenues by 2032. Natriuretic peptides, particularly B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), have become pivotal indicators for heart failure. The precision and sensitivity of these peptides in detecting cardiac stress and dysfunction have garnered widespread attention from healthcare providers. As technology advances, the development of novel natriuretic peptide assays promises enhanced diagnostic accuracy, providing clinicians with a powerful arsenal for early intervention and personalized treatment strategies.

The Congestive Heart Failure (CHF) application segment will generate high demand for cardiac biomarkers through 2032, driven by the global epidemic of heart failure. With a staggering rise in the number of CHF cases, the spectrum of CHF biomarkers, including troponins, creatine kinase-MB (CK-MB), and myoglobin, aid in the comprehensive evaluation of cardiac function. The integration of these biomarkers into routine clinical practice is reshaping the approach of managing heart failure, enabling timely interventions and improving patient outcomes.

Europe cardiac biomarkers industry is anticipated to record strong CAGR from 2023 to 2032, favored by a paradigm shift in cardiovascular care, with an increasing emphasis on preventive measures and personalized medicine. The product integration into routine clinical practice is gaining momentum, driven by collaborative efforts between healthcare institutions and innovative diagnostic companies. As the Europe region continues to embrace the latest advancements, the market is poised for sustained growth, ushering in a new era of cardiovascular healthcare across the continent.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & workings
• 1.3 Forecast calculations
• 1.4 Data Sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global cardiac biomarkers market 360 degree synopsis, 2018 - 2032
• 2.2 Regional trends
• 2.3 Product trends
• 2.4 Application trends
• 2.5 End-use trends

Chapter 3 Cardiac Biomarkers Industry Insights

• 3.1 COVID- 19 impact analysis
• 3.2 Industry ecosystem analysis
• 3.3 Technology landscape
• 3.4 Regulatory landscape
• 3.5 Industry impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Increase in prevalence of cardiovascular diseases
    • 3.5.1.2 Rise in the elderly population is leading to a higher prevalence of heart-related conditions
    • 3.5.1.3 Rising clinical research studies aimed at discovering new cardiac biomarkers
    • 3.5.1.4 Increase in point-of-care testing
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 Stringent regulatory frameworks
    • 3.5.2.2 Presence and advancement in cardiac imaging technologies
• 3.6 Growth potential analysis
  • 3.6.1 By product
  • 3.6.2 By application
  • 3.6.3 By end-use
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Abbott Diagnostics
  • 4.1.2 Roche Diagnostics
  • 4.1.3 Siemens Healthineers
• 4.2 Competitive analysis of major market players, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic outlook matrix, 2022

Chapter 5 Cardiac Biomarkers Market Size and Forecast, By Product, 2018-2032 (USD Million)

• 5.1 Key trends, by product
• 5.2 Troponins
• 5.3 Creatine kinase-MB (CK-MB)
• 5.4 Myoglobin
• 5.5 Natriuretic peptides
• 5.6 C-reactive protein (CRP)
• 5.7 Ischemia modified albumin
• 5.8 Other products

Chapter 6 Cardiac Biomarkers Market Size and Forecast, By Application, 2018-2032 (USD Million)

• 6.1 Key trends, by application
• 6.2 Congestive heart failure
• 6.3 Myocardial infarction
• 6.4 Acute coronary syndrome
• 6.5 Atherosclerosis
• 6.6 Other applications

Chapter 7 Cardiac Biomarkers Market Size and Forecast, By End-use, 2018-2032 (USD Million)

• 7.1 Key trends, by end-use
• 7.2 Hospital laboratory
• 7.3 Point of care testing facilities
• 7.4 Diagnostic facilities
• 7.5 Other end-users

Chapter 8 Cardiac Biomarkers Market Size and Forecast, By Region, 2018-2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Abbott Diagnostics
• 9.2 Roche Diagnostics
• 9.3 Siemens Healthineers
• 9.4 Beckman Coulter
• 9.5 Bio-Rad Laboratories
• 9.6 Ortho Clinical Diagnostics
• 9.7 Randox Laboratories
• 9.8 Quidel Corporation
• 9.9 Radiometer
• 9.10 Tosoh Corporation
• 9.11 Meso Scale Diagnostics (MSD)
• 9.12 Thermo Fisher Scientific
• 9.13 Luminex Corporation
• 9.14 Trinity Biotech
• 9.15 Biomerieux